Skip to main content
| News

Basel Healthtech fund successfully closed

07.12.2021

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first funds to invest in innovative European Healthtech firms in the growth phase.

Christoph Kausch, Managing Partner and Co-Founder of MTIP (img: MTIP)

MTIP has completed the fundraising phase for its second fund. As the Basel-based private equity firm announced on December 7, it raised a total of 250 million US dollars in capital commitments under its MTIP Fund II instead of the original target of 225 million US dollars.

The “dark green”, sustainability-focused fund is one of the first of its kind to specialize in the Healthtech sector. It invests in digital health companies and digitally-connected medical technology firms with the aim of supporting international expansion plans. “We are excited to announce the successful closing of our second fund and continue our mission to build the Healthtech leaders of tomorrow”, explains Christoph Kausch, Managing Partner at MTIP, in the press release.

New and existing investors in the fund included institutional investors, pension funds, family offices, hospitals, foundations and the health insurance firm Sanitas, further details of which can be found in the press release. Andreas Schönenberger, CEO of Sanitas, praised MTIP’s “unique expertise in Healthtech” that allows it to foster innovation “in this under-served private equity sector”.

MTIP writes further in the press release that it has already made successful investments in five companies as part of its MTIP Fund II: OvivaTrialbeeKoa HealthIntelligencia and Mediktor.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.